MaluCKKKahambaDMWalkerTD. Efficacy of sublingual lorazepam versus intrarectal diazepam for prolonged convulsions in sub-Saharan Africa. J Child Neurol. 2013. [Epub ahead of print].
2.
ScottRCBesagFMNevilleBG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353:623–626.
3.
MpimbazaANdeeziGStaedkeSRosenthalPJByarugabaJ. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics. 2008;121:e58–e64.
4.
McIntyreJRobertsonSNorrisE. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205–210.
5.
TroesterMMHastriterEVNgYT. Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures. J. Child Neurol. 2010;25:1468–1472.
6.
NgYTMagantiR. Status epilepticus in childhood. J Paediatr Child Health. 2013;49:432–437.
7.
SrinivasNR. Buccal and intranasal lorazepam pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?Eur J Clinic Pharmacol. 2012;68:1221–1223.
8.
AG DeBoerLG DeLeedeDD Breimer. Drug absorption by sublingual and rectal routes. Br J Anaesth. 1984;56:69–82.